American Well Stock (NYSE:AMWL)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$10.77

52W Range

$3.71 - $13.45

50D Avg

$9.43

200D Avg

$6.27

Market Cap

$181.12M

Avg Vol (3M)

$112.82K

Beta

1.70

Div Yield

-

AMWL Company Profile


American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

562

IPO Date

Sep 17, 2020

Website

AMWL Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Visits$94.29M$116.46M$119.48M
Others$22.63M$22.36M$27.20M
Platform Subscription$132.41M$115.54M$112.36M

Fiscal year ends in Dec 25 | Currency in USD

AMWL Financial Summary


Dec 25Dec 24Dec 23
Revenue-$254.36M$259.05M
Operating Income$-105.27M$-196.64M$-251.25M
Net Income$-95.70M$-208.14M$-675.16M
EBITDA$-58.37M$-173.34M$-640.80M
Basic EPS$-5.96$-13.88$-47.50
Diluted EPS$-5.96$-13.88$-47.50

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 06, 26 | 12:00 AM
Q4 25Feb 12, 26 | 5:00 PM
Q3 25Nov 04, 25 | 5:00 PM

Peer Comparison


TickerCompany
CAMPCAMP4 Therapeutics Corporation
GUTSFractyl Health, Inc.
RPTXRepare Therapeutics Inc.
ALXOALX Oncology Holdings Inc.
DTILPrecision BioSciences, Inc.
BMEABiomea Fusion, Inc.
IMUXImmunic, Inc.
ATYRaTyr Pharma, Inc.
EUDAEUDA Health Holdings Limited